EPCAM and neoplasm: The loss of membranous EpCAM expression has been found to significantly correlate with presence of lymph node metastasis and infiltrating tumor margins in colorectal cancers and in breast cancer, in addition to being linked to advanced stage of disease and poor overall survival [12], [13].